Alhasseny Khitam F, Mahmud Haseeb, Al-Samarraie Mohannad
Ibn Al Haitham Teaching Eye Hospital, Baghdad, Iraq.
Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Case Rep Ophthalmol. 2024 Oct 29;15(1):769-774. doi: 10.1159/000541776. eCollection 2024 Jan-Dec.
A 16-month-old girl presented with bilateral germline retinoblastoma, with advanced retinoblastoma in the right eye and severe orbital retinoblastoma in the left eye. Patients typically receive treatment with the multimodal protocol consisting of chemotherapy, surgery, and radiotherapy, which has improved survival.
Our patient elected for medical management with systemic chemotherapy instead of enucleation or exenteration. She received three blocks systemic chemotherapy consisting of vincristine sulfate, etoposide phosphate, and carboplatin, with irregular intervals between blocks over 3 years, due to poor compliance. Following chemotherapy, she had tumor regression in both eyes and no signs of active disease 13 years later.
This case represents an interesting favorable outcome of orbital retinoblastoma management with systemic chemotherapy alone despite inconsistency versus conventional multimodal protocol.
一名16个月大的女孩患有双侧遗传性视网膜母细胞瘤,右眼为晚期视网膜母细胞瘤,左眼为严重眼眶视网膜母细胞瘤。患者通常接受由化疗、手术和放疗组成的多模式治疗方案,这提高了生存率。
我们的患者选择了全身化疗而非眼球摘除术或眶内容剜除术进行药物治疗。她接受了三个疗程的全身化疗,化疗药物包括硫酸长春新碱、磷酸依托泊苷和卡铂,由于依从性差,三个疗程之间的间隔超过3年且不规律。化疗后,她双眼肿瘤均有消退,13年后无疾病活动迹象。
本病例显示了仅采用全身化疗治疗眼眶视网膜母细胞瘤的有趣且良好的结果,尽管与传统的多模式治疗方案不一致。